Phase II Study of Antineoplaston A10 and AS2-1 in Patients with Recurrent Diffuse Intrinsic Brain Stem Glioma: A Preliminary Report

By Burzynski S.R.  

Drugs in R&D, Vol. 4, Iss. 2, 2003-01 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial

By Galanis Evanthia   Buckner Jan   Maurer Matthew   Reid Joel   Kuffel Mary   Ames Matthew   Scheithauer Bernd   Hammack Julie   Pipoly George   Kuross Steven  

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 495-503

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

By Chang Susan   Wen Patrick   Cloughesy Timothy   Greenberg Harry   Schiff David   Conrad Charles   Fink Karen   Robins H.   Angelis Lisa   Raizer Jeffrey   Hess Kenneth   Aldape Ken   Lamborn Kathleen   Kuhn John   Dancey Janet   Prados Michael  

Investigational New Drugs, Vol. 23, Iss. 4, 2005-08 ,pp. : 357-361

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non–small cell lung cancer

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4165-4172

Blackwell Publishing

Access to resources Recommend Favorite

Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer

By Kato Ken  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1621-1627

Springer Publishing Company

Access to resources Recommend Favorite